Etude du potentiel de commercialisation d'unités de traitement d'effluents chargés en résidus de médicaments
Borremans, Gilles
Promoteur(s) : Tondeur, Jean
Date de soutenance : 1-sep-2017 • URL permanente : http://hdl.handle.net/2268.2/3500
Détails
Titre : | Etude du potentiel de commercialisation d'unités de traitement d'effluents chargés en résidus de médicaments |
Auteur : | Borremans, Gilles |
Date de soutenance : | 1-sep-2017 |
Promoteur(s) : | Tondeur, Jean |
Membre(s) du jury : | Smitz, Joseph
Maréchal, Brigitte Leboutte, Didier |
Langue : | Français |
Mots-clés : | [en] market study [en] wastewater [en] Pharmaceuticals [en] Hospitals [en] Environment [en] Europe [en] attractiveness [en] competitiveness [fr] Cockerill Maintenance & Ingiénerie |
Discipline(s) : | Sciences économiques & de gestion > Marketing |
Institution(s) : | Université de Liège, Liège, Belgique |
Diplôme : | Master en sciences de gestion, à finalité spécialisée en Marketing |
Faculté : | Mémoires de la HEC-Ecole de gestion de l'Université de Liège |
Résumé
[en] The project thesis discussed here aims to evaluate the potential of the market linked to wastewater treatment plants targeting pharmaceuticals.
Indeed, questions around the effects of pharmaceuticals on the environment have been raised in the recent years. With this idea in mind, CMI decided to develop a wastewater treatment plant dedicated to hospitals, who are responsible for 20% of this drug pollution. A special attention has been dedicated to hospitals from Belgium, Luxemburg, France, Germany, Netherlands, Switzerland and Denmark.
In order to know better hospitals, some research and analysis have been conducted. It turned out that there were a huge disparity, regarding hospitals’ organization, within the different countries studied. We could find some differences regarding the size of the markets, with Germany the biggest and Luxemburg the smallest, but also regarding the organization of the hospitals systems. These analysis have always showed that purchase motivations are regulations related and that at the moment the market is completely unregulated regarding pharmaceuticals in wastewater.
Regarding the competition, this innovative project is well positioned. Its process and its main characteristics are not yet present on the market. Indeed, the technological aspects of the products guarantee smaller prices and less maintenance requirements than the competition.
When taking into considerations all the characteristics of the market, two different elements stand out. First, CMI must confirm the efficiency of its product. Without this credibility, CMI will have strong difficulties to establish itself on different markets. Second, it seems that without a strong legislative canvas, potential of markets remains very limited. In order to tackle this problem, lobbying strategies at a regional level have been imagined. It is a combination of technology efficiency and strong lobbying that could lead CMI to success on this particular market.
Fichier(s)
Document(s)
Description:
Taille: 1.64 MB
Format: Adobe PDF
Citer ce mémoire
L'Université de Liège ne garantit pas la qualité scientifique de ces travaux d'étudiants ni l'exactitude de l'ensemble des informations qu'ils contiennent.